The Safety of Mohs Paste For Bleedings from Malignant Wound A Phase I Study
Phase 1
- Conditions
- malignant wound
- Registration Number
- JPRN-UMIN000023418
- Lead Sponsor
- Research Hospital, The Institute of Medical Science, The University of Tokyo
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 24
Inclusion Criteria
Not provided
Exclusion Criteria
1)Patients who have uncontrolled or active infection except the target malignant wound. 2)Patients who have allergy to zinc or fradiomycin sulfate. 3)Patients who have applied Mohs paste the same target lesion. 4)Patients who have applied the paste that dose not aim to prevent from protecting surface of malignant wound. 5)Patients who are used anticoagulation drug or antithrombocyte drug. 6)Patients whose malignant wound locates near body cavities or large blood vessels. 7)Patients who may be difficult to keep their safe or to evaluate this study.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method